Dittelbrunn, Germany

Haitham Ibrahim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haitham Ibrahim: Innovator in Blood Treatment Technology

Introduction

Haitham Ibrahim is a notable inventor based in Dittelbrunn, Germany. He has made significant contributions to the field of medical technology, particularly in blood treatment apparatuses. His innovative approach has led to the development of a unique method that enhances the efficiency of blood treatment processes.

Latest Patents

Haitham Ibrahim holds a patent for a method of determining the pressure in an extracorporeal circuit. This invention relates to a blood treatment apparatus, specifically a dialyzer. The method involves measuring the motor current of a blood pump and correlating it with blood flow to calculate pressure or related parameters. This advancement is crucial for improving the safety and effectiveness of blood treatment procedures.

Career Highlights

Ibrahim is currently employed at Fresenius Medical Care Deutschland GmbH, a leading company in the field of medical technology. His work focuses on developing innovative solutions that enhance patient care and treatment outcomes. With a patent portfolio that includes 1 patent, he continues to push the boundaries of medical technology.

Collaborations

Throughout his career, Haitham has collaborated with esteemed colleagues such as Alfred Gagel and Benedict Glaser. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Haitham Ibrahim's contributions to blood treatment technology exemplify the impact of innovation in healthcare. His patented method for determining pressure in extracorporeal circuits represents a significant advancement in the field. As he continues to work at Fresenius Medical Care, his efforts will undoubtedly lead to further improvements in patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…